Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2026iMetaMedOpen Access

N6‐Methyladenosine in Inflammatory Bowel Disease: An Emerging Regulator of Pathogenesis and a Novel Therapeutic Frontier

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJiaxian GuoThe University of TokyoYZYang ZhangPeking UniversityXWXin WangPeking University

Discussion

Loading...

Member takes

Implication

Review reveals the role of N6-methyladenosine in IBD pathogenesis, suggesting new therapeutic approaches.

Key Points

  • This review aims to elucidate the role of N6-methyladenosine in the pathogenesis of inflammatory bowel disease and its potential as a novel therapeutic target.
  • Reviewed previous studies focusing on m6A modification in IBD.
  • Analyzed the impact of m6A on intestinal barrier components.
  • Explored epigenetic mechanisms related to IBD progression.
  • N6-methyladenosine modification impacts all four components of the intestinal barrier.
  • m6A plays a pivotal role in the pathogenesis of inflammatory bowel disease.
  • Offers perspectives for improved IBD diagnosis, treatment, and prognosis.

Cite This Study

Guo et al. (2026) studied this question.

synapsesocial.com/papers/6a7ace3e3401087f2249e366https://doi.org/10.1002/imm3.70055
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of marker genes associated with N6-methyladenosine and autophagy in ulcerative colitis2024 · 2 citations
  2. 2Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice2024 · 12 citations
  3. 3Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn’s disease2019 · 71 citations
  4. 4The regulatory role of N6 ‐methyladenosine modification in the interaction between host and microbes2022 · 35 citations
  5. 5hucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the METTL3-Slc37a2-YTHDF1 axis2024 · 36 citations